semaglutide injection patent expiry Last week's of the for semaglutide—the active ingredient in Novo Nordisk's blockbuster drugs that are used to treat both diabetes and obesity—unleashed a flurry of launches of low-cost generic versions India's weight-loss drugs to get

ESSAY CONTEST WINNERS: A Cup's Perspective Alice Baratelli (Faculty/Practitioner Category) Global Health is All About Touching Lives Christopher Dukat (LMIC Trainee Category) Why being Shirtless in The Dominican will Make me a Better Doctor Kyle Nguyen (Trainee Category) HONORABLE MENTION: Balancing Measures Caitrin Kelly Infectious Conversations Frank N Working Towards Positive Freedom Anastazia Prost Bridging Silence Alia Pederson & Lauren Contreras Moderator: Christine Ngaruiya Come support the next generation of researchers by attending the oral abstracts presentations where emerging minds present their cutting-edge work, groundbreaking ideas, and fresh perspectives

These therapy options differ by half-lives and modes of administration (Table 1)

Semaglutide is not for insulin-dependent diabetics (type 1 diabetes)

317 , H49H59 (2019)